
Diamyd Medical AB: directors' dealings · Finland · FIN-FSA
FI:diamyd-medical-ab-75d781SE0020997468FIFI·FIN-FSAMcap 166M€Healthcare
Explore the full directors' dealings record of Diamyd Medical AB, a listed equity based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Healthcare sector, Diamyd Medical AB has recorded 1 reports. Market capitalisation: €166.4m. The latest transaction was filed on 28 April 2026 (Purchase). Among the most active insiders: Anders Essen-Möller. All data is openly available.
Financial data
FY ended August 2025 · cache
Analyst consensus
1 analysts1.55 €Target 1.55 €(+28%)1.55 €
Income statement
Revenue130 k€
Gross profit−3.7 M€-2850% margin
Net income−169.8 M€-130597.7% margin
Valuation
PER (forward)-1.6x
P/Book1.0x
Beta2.33
Balance sheet & cash
Market cap166.4 M€
Total debt30.7 M€
Free Cash Flow−137.2 M€
Profitability & ownership
ROE-142.5%
ROA-60.0%
% insiders23.0%
% institutions6.3%
Last declaration on 28 April 2026